M cell targeting by a Claudin 4 targeting peptide can enhance mucosal IgA responses

BMC Biotechnology

Volumn 12, Issue , 2012, Pages

  Lo, David D ^a   Ling, Jun ^a,b   Holly Eckelhoefer, A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Janet Weis Children s Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL TARGETING; CHOLERA TOXIN; CLAUDIN; IMMUNE SURVEILLANCE; INTRANASAL; LYMPHOID TISSUE; MUCOSAL IMMUNIZATION; NON-TARGETED; PEYER'S PATCHES; SINGLE-DOSE; TARGET RECEPTOR;

BODY FLUIDS; CELLS; CYTOLOGY; IMMUNIZATION; TISSUE;

PEPTIDES;

ADJUVANT; ANTIGEN; CHOLERA TOXIN; CLAUDIN 4; ENTEROTOXIN; HEMAGGLUTININ; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; CLAUDIN; HYBRID PROTEIN; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL TYPE; CONTROLLED STUDY; EPITHELIUM CELL; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; IMMUNOGLOBULIN BLOOD LEVEL; M CELL; MOUSE; MUCOSA; NONHUMAN; PEYER PATCH; TH2 CELL; VACCINATION; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CHEMISTRY; CYTOLOGY; DRUG DELIVERY SYSTEM; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; METABOLISM; METHODOLOGY;

MUS;

ADMINISTRATION, INTRANASAL; ANIMALS; CLAUDINS; DRUG DELIVERY SYSTEMS; EPITHELIAL CELLS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; IMMUNOGLOBULIN A; INFLUENZA VACCINES; MICE; MICE, INBRED BALB C; PEPTIDES; PEYER'S PATCHES; RECOMBINANT FUSION PROTEINS;

EID: 84857947313     PISSN: None     EISSN: 14726750     Source Type: Journal    
DOI: 10.1186/1472-6750-12-7     Document Type: Article

References (36)

1. Bergqvist P, Stensson A, Lycke NY, Bemark M. T cell-independent IgA class switch recombination is restricted to the GALT and occurs prior to manifest germinal center formation. J Immunol 2010, 184:3545-3553. 10.4049/jimmunol.0901895, 20207993.
2. Craig SW, Cebra JJ. Peyer's patches: an enriched source of precursors for IgA-producing immunocytes in the rabbit. J Exp Med 1971, 134:188-200. 10.1084/jem.134.1.188, 2139023, 4934147.
3. Martinoli C, Chiavelli A, Rescigno M. Entry route of Salmonella typhimurium directs the type of induced immune response. Immunity 2007, 27:975-984. 10.1016/j.immuni.2007.10.011, 18083577.
4. Shikina T, Hiroi T, Iwatani K, Jang MH, Fukuyama S, Tamura M, Kubo T, Ishikawa H, Kiyono H. IgA class switch occurs in the organized nasopharynx- and gut-associated lymphoid tissue, but not in the diffuse lamina propria of airways and gut. J Immunol 2004, 172:6259-6264.
5. Rajapaksa TE, Lo DD. Microencapsulation of Vaccine Antigens and Adjuvants for Mucosal Targeting. Current Immunology Reviews 2010, 6:29-37.
6. Niess JH, Brand S, Gu X, Landsman L, Jung S, McCormick BA, Vyas JM, Boes M, Ploegh HL, Fox JG, Littman DR, Reinecker H-C. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 2005, 307:254-258. 10.1126/science.1102901, 15653504.
7. Rescigno M, Urbano M, Valzasina B, Francolini M, Rotta G, Bonasio R, Granucci F, Kraehenbuhl JP, Ricciardi-Castagnoli P. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2001, 2:361-367. 10.1038/86373, 11276208.
8. Mishra N, Tiwari S, Vaidya B, Agrawal GP, Vyas SP. Lectin anchored PLGA nanoparticles for oral mucosal immunization against hepatitis B. J Drug Target 2011, 19:67-78. 10.3109/10611861003733946, 20334603.
9. Nochi T, Yuki Y, Matsumura A, Mejima M, Terahara K, Kim D-Y, Fukuyama S, Iwatsuki-Horimoto K, Kawaoka Y, Kohda T, Kozaki S, Igarashi O, Kiyono H. A novel M cell-specific carbohydrate-targeted mucosal vaccine effectively induces antigen-specific immune responses. J Exp Med 2007, 204:2789-2796. 10.1084/jem.20070607, 2118513, 17984304.
10. Wang X, Kochetkova I, Haddad A, Hoyt T, Hone DM, Pascual DW. Transgene vaccination using Ulex europaeus agglutinin I (UEA-1) for targeted mucosal immunization against HIV-1 envelope. Vaccine 2005, 23:3836-3842. 10.1016/j.vaccine.2005.02.023, 15893622.
11. Garinot M, Fiévez V, Pourcelle V, Stoffelbach F. des Rieux A, Plapied L, Theate I, Freichels H, Jérôme C, Marchand-Brynaert J, Schneider Y-J, Préat V: PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination. J Control Release 2007, 120:195-204. 10.1016/j.jconrel.2007.04.021, 17586081.
12. Rynda A, Maddaloni M, Mierzejewska D, Ochoa-Repáraz J, Maslanka T, Crist K, Riccardi C, Barszczewska B, Fujihashi K, McGhee JR, Pascual DW. Low-dose tolerance is mediated by the microfold cell ligand, reovirus protein sigma1. J Immunol 2008, 180:5187-5200. 2629740, 18390700.
13. Suzuki H, Sekine S, Kataoka K, Pascual DW, Maddaloni M, Kobayashi R, Fujihashi K, Kozono H, McGhee JR, Fujihashi K. Ovalbumin-protein sigma 1 M-cell targeting facilitates oral tolerance with reduction of antigen-specific CD4+ T cells. Gastroenterology 2008, 135:917-925. 10.1053/j.gastro.2008.05.037, 2579966, 18565333.
14. Wu Y, Wang X, Csencsits KL, Haddad A, Walters N, Pascual DW. M cell-targeted DNA vaccination. Proc Natl Acad Sci USA 2001, 98:9318-9323. 10.1073/pnas.161204098, 55418, 11459939.
15. Lo D, Tynan W, Dickerson J, Scharf M, Cooper J, Byrne D, Brayden D, Higgins L, Evans C, O'Mahony DJ. Cell culture modeling of specialized tissue: identification of genes expressed specifically by follicle-associated epithelium of Peyer's patch by expression profiling of Caco-2/Raji co-cultures. Int Immunol 2004, 16:91-99. 10.1093/intimm/dxh011, 14688064.
16. Wang J, Lopez-Fraga M, Rynko A, Lo DD. TNFR and LTbetaR agonists induce follicle-associated epithelium and M cell specific genes in rat and human intestinal epithelial cells. Cytokine 2009, 47:69-76. 10.1016/j.cyto.2009.05.001, 2756805, 19501526.
17. Clark RT, Hope A, Lopez-Fraga M, Schiller N, Lo DD. Bacterial particle endocytosis by epithelial cells is selective and enhanced by tumor necrosis factor receptor ligands. Clin Vaccine Immunol 2009, 16:397-407. 10.1128/CVI.00210-08, 2650861, 19129472.
18. Fujita K, Katahira J, Horiguchi Y, Sonoda N, Furuse M, Tsukita S. Clostridium perfringens enterotoxin binds to the second extracellular loop of claudin-3, a tight junction integral membrane protein. FEBS Lett 2000, 476:258-261. 10.1016/S0014-5793(00)01744-0, 10913624.
19. Sonoda N, Furuse M, Sasaki H, Yonemura S, Katahira J, Horiguchi Y, Tsukita S. Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: Evidence for direct involvement of claudins in tight junction barrier. J Cell Biol 1999, 147:195-204. 10.1083/jcb.147.1.195, 2164970, 10508866.
20. Ling J, Liao H, Clark R, Wong MSM, Lo DD. Structural constraints for the binding of short peptides to claudin-4 revealed by surface plasmon resonance. J Biol Chem 2008, 283:30585-30595. 10.1074/jbc.M803548200, 2576538, 18782762.
21. Rajapaksa TE, Stover-Hamer M, Fernandez X, Eckelhoefer HA, Lo DD. Claudin 4-targeted protein incorporated into PLGA nanoparticles can mediate M cell targeted delivery. J Control Release 2010, 142:196-205. 10.1016/j.jconrel.2009.10.033, 2823968, 19896996.
22. Rajapaksa TE, Bennett KM, Hamer M, Lytle C, Rodgers VGJ, Lo DD. Intranasal M cell uptake of nanoparticles is independently influenced by targeting ligands and buffer ionic strength. J Biol Chem 2010, 285:23739-23746. 10.1074/jbc.M110.126359, 2911333, 20511224.
23. Hsieh EH, Fernandez X, Wang J, Hamer M, Calvillo S, Croft M, Kwon BS, Lo DD. CD137 is required for M cell functional maturation but not lineage commitment. Am J Pathol 2010, 177:666-676. 10.2353/ajpath.2010.090811, 2913358, 20616340.
24. Gerhard W, Yewdell J, Frankel ME, Webster R. Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies. Nature 1981, 290:713-717. 10.1038/290713a0, 6163993.
25. Tao Y, Strelkov SV, Mesyanzhinov VV, Rossmann MG. Structure of bacteriophage T4 fibritin: a segmented coiled coil and the role of the C-terminal domain. Structure 1997, 5:789-798. 10.1016/S0969-2126(97)00233-5, 9261070.
26. Castigli E, Scott S, Dedeoglu F, Bryce P, Jabara H, Bhan AK, Mizoguchi E, Geha RS. Impaired IgA class switching in APRIL-deficient mice. Proc Natl Acad Sci USA 2004, 101:3903-3908. 10.1073/pnas.0307348101, 374342, 14988498.
27. Castigli E, Wilson SA, Scott S, Dedeoglu F, Xu S, Lam K-P, Bram RJ, Jabara H, Geha RS. TACI and BAFF-R mediate isotype switching in B cells. J Exp Med 2005, 201:35-39. 10.1084/jem.20032000, 2212754, 15630136.
28. Sakurai D, Hase H, Kanno Y, Kojima H, Okumura K, Kobata T. TACI regulates IgA production by APRIL in collaboration with HSPG. Blood 2007, 109:2961-2967.
29. Massacand JC, Kaiser P, Ernst B, Tardivel A, Bürki K, Schneider P, Harris NL. Intestinal bacteria condition dendritic cells to promote IgA production. PLoS ONE 2008, 3:e2588. 10.1371/journal.pone.0002588, 2432026, 18596964.
30. Finkelman FD, Holmes J, Katona IM, Urban JF, Beckmann MP, Park LS, Schooley KA, Coffman RL, Mosmann TR, Paul WE. Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol 1990, 8:303-333. 10.1146/annurev.iy.08.040190.001511, 1693082.
31. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989, 7:145-173. 10.1146/annurev.iy.07.040189.001045, 2523712.
32. Hahn A, Thiessen N, Pabst R, Buettner M, Bode U. Mesenteric lymph nodes are not required for an intestinal immunoglobulin A response to oral cholera toxin. Immunology 2010, 129:427-436. 10.1111/j.1365-2567.2009.03197.x, 2826687, 19922419.
33. Kataoka K, Fujihashi K, Sekine S, Fukuiwa T, Kobayashi R, Suzuki H, Nagata H, Takatsu K, Shizukuishi S, McGhee JR, Fujihashi K. Nasal cholera toxin elicits IL-5 and IL-5 receptor alpha-chain expressing B-1a B cells for innate mucosal IgA antibody responses. J Immunol 2007, 178:6058-6065.
34. Quan F-S, Vunnava A, Compans RW, Kang S-M. Virus-like particle vaccine protects against 2009 H1N1 pandemic influenza virus in mice. PLoS ONE 2010, 5:e9161. 10.1371/journal.pone.0009161, 2820088, 20161790.
35. Kakutani H, Kondoh M, Fukasaka M, Suzuki H, Hamakubo T, Yagi K. Mucosal vaccination using claudin-4-targeting. Biomaterials 2010, 31:5463-5471. 10.1016/j.biomaterials.2010.03.047, 20398936.
36. Harris NL, Spoerri I, Schopfer JF, Nembrini C, Merky P, Massacand J, Urban JF, Lamarre A, Burki K, Odermatt B, Zinkernagel RM, Macpherson AJ. Mechanisms of neonatal mucosal antibody protection. J Immunol 2006, 177:6256-6262.